Filgrastim Completed Phase 2 Trials for Chemotherapy Induced Neutropenia Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive Care2
clinicaltrials.gov IdentifierTitleDrugs
NCT01569087Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer